Posts tagged as:

Cox-2 inhibitor

The world decides the fate of the Cox-2s

by James on 19 February 2005

I hate to bring up the topic of Cox-2 inhibitors one more time, but I did want to let you know in brief what has been happening.  In various places in the world, the judgment has been much the same.  For example, Europe and the USA seem to be both deciding to allow Cox-2 inhibitors [...]

{ 0 comments }

Questions raised by the Cox-2 inhibitor frenzy…

by James on 16 February 2005

Cox-2 inhibitors continue to be at the forefront of the news, partly because of the huge economic impact that pulling them will have on some drug companies, partly because of the impact it will have on patients (they were generally prescribed for arthritis, but sometimes for headache), and partly because of the chance it gives [...]

{ 0 comments }

FDA Health Advisory – Bextra, Celebrex and Aleve

by James on 24 December 2004

Yesterday the American FDA issued a health advisory regarding the drugs Cox-2 drugs Bextra and Celebrex, and the NSAID naproxen.  Basically, they’re recommending that caution should be exercised with the drugs Bextra and Celebrex.  Recent studies seem to indicate that they may increase the risk of heart attack and stroke.  There is also concern about [...]

{ 0 comments }

Cox-2 Inhibitors – in the news again

by James on 22 December 2004

The information is coming in so fast that it’s hard to keep up to date! Many of you read in the last issue of HeadWay about emerging concerns about drugs such as Celebrex and Bextra. Now these drugs are getting more attention, and more studies are being done. You will notice some updates in this [...]

{ 0 comments }